Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03075826
Title A Phase II Study of SGI-110 in Philadelphia-Negative Myeloproliferative Neoplasms
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Weill Medical College of Cornell University
Indications

myelodysplastic/myeloproliferative neoplasm

myelodysplastic syndrome

chronic myeloid leukemia

Therapies

Guadecitabine

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.